Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
FDA Issues New Guidance on How Allergens Should Be Included on Food Labels The new draft guidance adds sesame to the list of major food allergens for the first time. December 5, 2022 Martha Garcia Add Your Comments Federal regulators are calling for food labels to have more clearly marked allergy warnings for some of the most common food allergens, such as milk, peanuts, eggs, shellfish and soybeans. Last week, the Food and Drug Administration (FDA) issued a press release announcing new draft and final guidance focusing on common food allergens that should be listed on food labels in the United States. The guidance documents are designed to help the food industry meet requirements to list any major food allergen on the labels of FDA-regulated foods. The goal is to make the labels easy to read and to make warnings of common allergens easily spotted, so consumers can avoid ingredients they may be allergic to or have sensitivities to simply by looking at food labels and the ingredient list. The first draft guidance, Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the Federal Food, Drug, and Cosmetic Act (Edition 5): Guidance for Industry, updates changes to the previous edition, which was first published in 2006. The new guidance also adheres to the Food Allergy Safety, Treatment, Education, and Research Act of 2021 (FASTER) and the Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA), which requires foods or ingredients that contain a major food allergen to be specifically labeled with the name of the allergen. The FDA originally identified eight major food allergens: milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soybeans. The new draft guidance introduces sesame as an addition to that list. This addition is effective January 2023, making it the ninth major food allergen recognized in the U.S. Allergen Labeling Guidance Exceptions The guidance indicates that if an ingredient from a food allergen source does not contain protein, it does not need to be listed as a food allergen. This can include oils, flavoring, and colors that may come from allergens but donโt contain protein. Roots, leaves, stems, bark, or other plant parts that are separate from the tree nut or allergic portion are not considered allergens and do not need to be listed on the label. A major allergen that is unintentionally mixed into food via cross-contamination is also not subject to allergen labeling. This can include contamination from the use of shared storage, production equipment, or transportation. Foods that do not have major allergens as ingredients do not need a โcontainsโ statement, even if consumers are sensitive to a certain product. For example, gluten is not considered a major allergen, even though many people experience sensitivities to it, so a โcontainsโ statement is not necessary for gluten. If a dietary supplement does not have an ingredient list, the โcontainsโ statement must be included on the package. Food allergens do not need to be listed for cosmetics or household cleaning products. The guidance also updates labeling concerning fish and shellfish, as well as including images of examples of labeling requirements. The second guidance is a final guidance issued by the FDA with the same title. This guidance focuses on finalizing the fourth edition of the guidance published in 2006 and includes information for questions and answers to the previous edition that was not changed. Do You Know about… Spinal Cord Stimulator lawsuits Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know Aboutโฆ Spinal Cord Stimulator lawsuits Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA has opened public comments for the draft guidance for 60 days from the publication of the guidance in the Federal Register. Comments can be submitted electronically on www.regulations.gov. Comments can also be submitted via mail with Docket ID: FDA-2022-D-0099 to: Dockets Management Staff Food and Drug Administration 5630 Fishers Lane, Rm 1061 Rockville, MD 20852 Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Allergic Reaction, Allergy, Food, Food Labeling More Lawsuit Stories Infections After Colonoscopy, ERCP May Result in Lawsuits Over Olympus Scope Problems March 27, 2026 Final Pretrial Conference in Bard PowerPort Lawsuit To Be Held April 9 March 27, 2026 Amazon Instant Pot Lawsuit Claims Pressure Cooker Defects Caused Serious Injuries March 27, 2026 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Infections After Colonoscopy, ERCP May Result in Lawsuits Over Olympus Scope Problems (Posted: 2 days ago) Patients are developing serious infections after colonoscopy and ERCP procedures, as concerns grow that reusable endoscopes may not be fully sterilized, leading to new lawsuits over contaminated medical devices. MORE ABOUT: SCOPE INFECTION LAWSUIT Drug Makers Agree Dupixent Cancer Lawsuits Should Be Centralized in MDL (Posted: 3 days ago) Regeneron and Sanofi-Aventis agree with calls to consolidate all Dupixent cancer lawsuits currently spread throughout the federal court system before one judge. MORE ABOUT: DUPIXENT LAWSUITEnlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims (03/16/2026)Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks (03/09/2026)Dupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges (02/25/2026) Depo-Provera Meningioma Lawyers Reappointed to MDL Leadership Roles (Posted: 4 days ago) A group of about 70 Depo-Provera meningioma lawyers have been reappointed to key leadership roles in the litigation, as thousands of women seek compensation for brain tumors they say were caused by the birth control shots. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Symptoms Reported Among Birth Control Users (03/19/2026)Depo Injection Lawsuit Claims Birth Control Shot Caused Meningioma Brain Tumor (03/17/2026)Nearly 4,000 Women Are Pursuing a Depo-Provera Lawsuit After Developing Brain Tumors (03/04/2026)
Infections After Colonoscopy, ERCP May Result in Lawsuits Over Olympus Scope Problems (Posted: 2 days ago) Patients are developing serious infections after colonoscopy and ERCP procedures, as concerns grow that reusable endoscopes may not be fully sterilized, leading to new lawsuits over contaminated medical devices. MORE ABOUT: SCOPE INFECTION LAWSUIT
Drug Makers Agree Dupixent Cancer Lawsuits Should Be Centralized in MDL (Posted: 3 days ago) Regeneron and Sanofi-Aventis agree with calls to consolidate all Dupixent cancer lawsuits currently spread throughout the federal court system before one judge. MORE ABOUT: DUPIXENT LAWSUITEnlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims (03/16/2026)Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks (03/09/2026)Dupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges (02/25/2026)
Depo-Provera Meningioma Lawyers Reappointed to MDL Leadership Roles (Posted: 4 days ago) A group of about 70 Depo-Provera meningioma lawyers have been reappointed to key leadership roles in the litigation, as thousands of women seek compensation for brain tumors they say were caused by the birth control shots. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Symptoms Reported Among Birth Control Users (03/19/2026)Depo Injection Lawsuit Claims Birth Control Shot Caused Meningioma Brain Tumor (03/17/2026)Nearly 4,000 Women Are Pursuing a Depo-Provera Lawsuit After Developing Brain Tumors (03/04/2026)